Foley Represents ARCHIMED in Acquisition of Majority Stake in Innovative Skincare Company Cellese

Foley & Lardner LLP represented global private equity health care specialist ARCHIMED in its acquisition of a majority stake in Cellese, a developer of innovative topical dermo cosmetics sold under the AnteAGE brand name.

With offices in Europe, North America, and Asia, ARCHIMED is a leading investment firm focused exclusively on health care industries. Its mix of operational, medical, scientific, and financial expertise allows ARCHIMED to serve as both a strategic and financial partner to health care businesses. Prioritized areas of focus include Biopharma Products, Consumer Health, Healthcare IT, In Vitro Diagnostics, Life Science Tools & Biologic Services, MedTech, and Pharma Services. 

Partnering with ARCHIMED provides the strategic resources needed to further accelerate Cellese’s science-based edge in regenerative skincare and skin-longevity treatments.

The Foley team included partners Thomas Carlucci, Louis Lehot, Brandee Diamond, and Eric Chow and associates Talita Duarte, Trevor Mullin, and Mackenzie Barrett.

Additional Foley attorneys included Nathan Beaver (Food and Drug Regulatory), Rishi Sodhi and Sonia Kothari (Tax), Andrew Rawlins and Sarah Waste (Technology Transactions), Antoinette Konski and Katherine Califa (Intellectual Property), Casey Knapp and Cullen Werwie (Executive Compensation), Krista Cabrera (Employment), Alexandra Jashinsky (Real Estate), Steven Millendorf (Data Privacy), and Sarah Slack (Environmental).